Advance Track

G4A is a visionary organization in the digital health industry that identifies and partners with companies that are poised to revolutionize healthcare and drastically improve people’s lives. We provide digital health funding to health tech startups looking for commercial partnerships. What our partners are accomplishing is exciting, and is addressing the health needs of people.

Even for larger businesses, it can be challenging to establish commercial partnerships with pharmaceutical companies. G4A acts as a navigator - making connections between digital health companies and the right stakeholders within Bayer to more effectively produce meaningful outcomes.

How can the Advance Track transform your product?

Global Experts who can take your product to the next level

Partner up with a
leading player in
global pharma

Our mutually beneficial, individually negotiated partnerships can be in the form of - among others - M&As, MSAs, Commercial Collaborations, Licensing Agreements and Large-Scale Investments.

Global experts who
can take your product
to the next level

As one of the world’s largest players in pharma, and with more than 150 years of experience, Bayer is a great partner for your company to take off

advanced track

Our success stories

53+

Advance Track companies

$998M

Total funding raised

$1.8B

Total Alumni Value

Our success stories

53+

Advance Track companies

$998M

Total funding raised

$1.8B

Total Alumni Value